Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9QZS8

Entry ID Method Resolution Chain Position Source
AF-Q9QZS8-F1 Predicted AlphaFoldDB

44 variants for Q9QZS8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388548116 11 K>M No EVA
rs3391307570 72 D>A No EVA
rs3391445632 73 M>L No EVA
rs247000946 101 S>I No EVA
rs1132686343 109 R>Q No EVA
rs257721412 115 P>L No EVA
rs226828653 131 L>P No EVA
rs3388547545 134 T>M No EVA
rs244510119 135 A>V No EVA
rs3388545234 185 K>N No EVA
rs3388541160 190 S>T No EVA
rs3388548571 211 R>H No EVA
rs3388545507 216 Y>F No EVA
rs3388545478 242 T>I No EVA
rs3391412662 291 L>H No EVA
rs3391421959 296 V>E No EVA
rs3388543802 297 G>C No EVA
rs3388545431 312 C>S No EVA
rs3391454272 370 D>H No EVA
rs3391380627 371 G>R No EVA
rs3388547515 388 C>F No EVA
rs3388544127 426 T>I No EVA
rs257219827 427 P>H No EVA
rs27207944 451 T>A No EVA
rs242928396 452 P>S No EVA
rs213093176 461 A>G No EVA
rs583419050 462 P>S No EVA
rs583419050 462 P>T No EVA
rs236420539 464 A>G No EVA
rs3388548090 464 A>P No EVA
rs3388543499 476 S>* No EVA
rs3388545417 476 S>P No EVA
rs3388541098 484 D>V No EVA
rs3391451759 534 K>Q No EVA
rs220602620 537 T>I No EVA
rs3388545412 541 V>I No EVA
rs3388549127 584 L>P No EVA
rs3388548112 606 Q>H No EVA
rs3388538740 704 R>* No EVA
rs3388544088 708 G>D No EVA
rs13469758 718 P>L No EVA
rs3388548543 739 H>L No EVA
rs3388546468 748 E>D No EVA
rs3388544096 767 V>A No EVA

No associated diseases with Q9QZS8

3 regional properties for Q9QZS8

Type Name Position InterPro Accession
domain Rhodanese-like domain 113 - 217 IPR001763
domain Rhodanase, C-terminal 220 - 286 IPR022111
domain tRNA uridine(34) hydroxylase, N-terminal 3 - 94 IPR040503

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Cell membrane ; Peripheral membrane protein
  • Cell projection, axon
  • Cell projection, ruffle membrane
  • Associated with the membrane when EGF-stimulated (PubMed:10692442)
  • Expressed at the cortical actin ring in B cells (PubMed:20956287)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
axon The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
ruffle membrane The portion of the plasma membrane surrounding a ruffle.

3 GO annotations of molecular function

Name Definition
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.
phosphotyrosine residue binding Binding to a phosphorylated tyrosine residue within a protein.
transmembrane receptor protein tyrosine kinase adaptor activity The binding activity of a molecule that brings together a transmembrane receptor protein tyrosine kinase and one or more other molecules, permitting them to function in a coordinated way.

3 GO annotations of biological process

Name Definition
positive regulation of peptidyl-serine phosphorylation Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
small GTPase mediated signal transduction The series of molecular signals in which a small monomeric GTPase relays a signal.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q58DL5 BCAR3 Breast cancer anti-estrogen resistance protein 3 homolog Bos taurus (Bovine) PR
O75815 BCAR3 Breast cancer anti-estrogen resistance protein 3 Homo sapiens (Human) PR
Q9BRG2 SH2D3A SH2 domain-containing protein 3A Homo sapiens (Human) PR
Q8N5H7 SH2D3C SH2 domain-containing protein 3C Homo sapiens (Human) PR
Q9QZK2 Bcar3 Breast cancer anti-estrogen resistance protein 3 homolog Mus musculus (Mouse) PR
10 20 30 40 50 60
MTEMPKKTGR KFKFFKFKGL GSLSNLPRSF SLRRSSASAS IRSCPEPDTF EATQDDMVTL
70 80 90 100 110 120
PKSPPAYARS SDMYSHMGTM PRPNIKKAQK QQAVQKAQEV SRESHLVSRR LPEPPDLEAA
130 140 150 160 170 180
KEAGEGTEAL LEDTAPSAVE VDPMRELEDL TVDTEKEQVP GDVSPERTAA ELEAAGDYVK
190 200 210 220 230 240
FSKEKYILDS SPEKLHKELE EELKLSSTDL RSHAWYHGRI PREVSETLVQ RNGDFLIRDS
250 260 270 280 290 300
LTSLGDYVLT CRWHNQALHF KINKVVVKAG ESYTHIRYLF EQESFDHVPA LVRYHVGSRK
310 320 330 340 350 360
AVSEQSGAII YCPVNRTFPL RYLEASYGLS QGSSKTASPA SPSGSKGSHM KRRSITMTDG
370 380 390 400 410 420
LTTDKVTRSD GCPNSTSLPH PRDSIRNCAL SMDQIPDLHS PLSPISESPS SPAYSTVTRV
430 440 450 460 470 480
HAPSATPSTS AQPASPVARR SSEPQLCPGN TPKPPGESDR APHASPSHTL CKASPSPSLS
490 500 510 520 530 540
SYSDPDSGHY CQLQPPVRGS REQAAGETPR KARGSGERQK ELLENGVSDG EWGKTFTVPV
550 560 570 580 590 600
VEATSSFNLA TFQSQLIPKE NRPLEVALLR KVKELLSEVD ARTLARHVTK VDCLVARILG
610 620 630 640 650 660
VTKEMQTLMG VRWGMELLTL PHGRQLRLDL LERFHTMSIM LAVDILGCTG SAEERAALLH
670 680 690 700 710 720
KTIQLAAELR GTMGNMFSFA AVMGALEMAQ ISRLEQTWMT LRQRHTEGAI LYEKKLKPFL
730 740 750 760 770 780
KSLNEGKEGP PLSNTTFPHV LPFITLLECD SAPAEGPEPW GSTEHGVEVV LAHLEAARTV
790 800 810 820 830 840
AHHGGLYHTN AEVKLQGFQA RPELLEVFST EFQMRLLWGS QGANSSQAWR YEKFDKVLTA
850
LSHKLEPAIR SSEL